Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  JAK2 inhibitor WP1066
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
JAK2 inhibitor WP1066 in Treating Patients with Central Nervous System Melanoma and Recurrent Glioblastoma Multiforme
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 2012-0358, NCI-2015-00163, NCT01904123
Start Over